In 2011, 332 students—258 in the U.S. and 74 in Europe—participated in the Amgen Scholars Program. The Scholars were picked from about 3,400 applicants, more than twice the number of applicants when the program began in 2007. The number of applications has grown steadily since the program’s debut.
The Program continues to attract top students, allowing them an opportunity for hands-on research in the labs of leading academic scientists at 10 host institutions within the U.S. and 3 in Europe.
Biology is the most common major among 2011 Amgen Scholars, but others popular areas of study include biochemistry, bioengineering, chemistry and neuroscience. Most participants (63%) expect to graduate in 2012, and they are firmly focused on advanced degrees: 66% of them report that they plan to pursue a PhD and 32% plan to earn an MD/PhD.
Amgen Scholars in the U.S.
- In 2011, U.S. participants came from 43 U.S. states/territories. The most commonly listed home states are California (27%), Maryland (6%), and Pennsylvania (6%).
- The 2011 class represents 132 colleges and universities.
-
56% of U.S. participants are female, and 44% are male.
Amgen Scholars in Europe
- In 2011, European participants came from 25 countries. The most commonly listed home countries are the United Kingdom (16%), Poland (10%), and Germany (8%).
- Participants are enrolled in 39 colleges and universities across 16 countries.
- 62% of European participants are female, and 38% are male.
